These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
737 related items for PubMed ID: 14505088
1. Profiling penciclovir susceptibility and prevalence of resistance of herpes simplex virus isolates across eleven clinical trials. Sarisky RT, Bacon TH, Boon RJ, Duffy KE, Esser KM, Leary J, Locke LA, Nguyen TT, Quail MR, Saltzman R. Arch Virol; 2003 Sep; 148(9):1757-69. PubMed ID: 14505088 [Abstract] [Full Text] [Related]
7. Topical application of penciclovir cream for the treatment of herpes simplex facialis/labialis: a randomized, double-blind, multicentre, aciclovir-controlled trial. Lin L, Chen XS, Cui PG, Wang JB, Guo ZP, Lu NZ, Bi ZG, Jia H, Yang XY, Topical Penciclovir Clinical Study Group. J Dermatolog Treat; 2002 Jun; 13(2):67-72. PubMed ID: 12060504 [Abstract] [Full Text] [Related]
9. Susceptibility to acyclovir of herpes simplex virus isolates obtained between 1977 and 1996 in Japan. Hasegawa T, Kawana T, Okuda T, Horii M, Tsukada T, Shiraki K. J Med Virol; 2001 Jan; 63(1):57-63. PubMed ID: 11130888 [Abstract] [Full Text] [Related]
10. Valacyclovir for herpes simplex virus infection: long-term safety and sustained efficacy after 20 years' experience with acyclovir. Tyring SK, Baker D, Snowden W. J Infect Dis; 2002 Oct 15; 186 Suppl 1():S40-6. PubMed ID: 12353186 [Abstract] [Full Text] [Related]
11. [Acyclovir-resistant herpes simplex virus infections in immunocompromised patients]. Jansen CL, Maris-Tegeler WG, Wertheim-van Dillen PM, Frissen PH, Weiland HT, van der Noordaa J. Ned Tijdschr Geneeskd; 1992 Feb 08; 136(6):280-4. PubMed ID: 1311058 [Abstract] [Full Text] [Related]
12. [Clinical utility of susceptibility testing of herpes simplex virus to acyclovir]. Otegui M, Rabella N, Labeaga R, Herrero M, Margall N, Muñoz JM, Prats G. Rev Esp Quimioter; 2001 Dec 08; 14(4):351-7. PubMed ID: 11856981 [Abstract] [Full Text] [Related]
13. Factors that affect in vitro measurement of the susceptibility of herpes simplex virus to nucleoside analogues. Weinberg A, Leary JJ, Sarisky RT, Levin MJ. J Clin Virol; 2007 Feb 08; 38(2):139-45. PubMed ID: 17169605 [Abstract] [Full Text] [Related]
14. [Resistance to virostatic agents in Herpes viruses: mechanism, incidence and clinical significance]. Reusser P. Schweiz Med Wochenschr; 1994 Jan 29; 124(4):152-8. PubMed ID: 8128197 [Abstract] [Full Text] [Related]
16. Valaciclovir: a review of its long term utility in the management of genital herpes simplex virus and cytomegalovirus infections. Ormrod D, Scott LJ, Perry CM. Drugs; 2000 Apr 29; 59(4):839-63. PubMed ID: 10804039 [Abstract] [Full Text] [Related]
17. Sensitivity of HSV strains isolated before and after treatment with acyclovir. Svennerholm B, Vahlne A, Löwhagen GB, Widell A, Lycke E. Scand J Infect Dis Suppl; 1985 Apr 29; 47():149-54. PubMed ID: 3006229 [Abstract] [Full Text] [Related]